A5021242627- Congenital Heart Disease Studies
- Cardiomyopathy and Myosin Studies
- COVID-19 and healthcare impacts
- Intensive Care Unit Cognitive Disorders
- Dialysis and Renal Disease Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Lipoproteins and Cardiovascular Health
- Frailty in Older Adults
- Cardiovascular Function and Risk Factors
Medical University of Silesia
2024
ERN GUARD-Heart
2024
Pomeranian Medical University
2022
Due to the unpredictable nature of COVID-19, there is a need identify patients at high risk severe course disease and higher mortality rate.
Background: Regardless of genetic origin and recommended screening methods, hypertrophic cardiomyopathy (HCM) is commonly diagnosed late in the advanced stages disease. The aim this study was to analyse case history patients with HCM order obtain an initiation diagnostic process. Methods: This a retrospective, tertiary, single-centre cohort analysis 85 consecutive pts (mean age at time diagnosis: 51 ± 15 years; F/M: 42/43) who were hospitalized during period from 1 January 2013 31 December...